THOR News and Press, Synthorx Inc. From 12/24/19

NEW YORK, NY / ACCESSWIRE / December 24, 2019 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Synthorx , Inc. (NASDAQ:THOR) The investigation concerns whether Synthorx and its board of directors violated the federal securities law...

Synthorx (NASDAQ: THOR ) reveals in a filing that it received a $70/share bid after it had accepted Sanofi's (NASDAQ: SNY ) $68 offer. More news on: Synthorx, Inc., Sanofi, Healthcare stocks news, Stocks on the move Read more ...

Sanofi ( SNY ) announced that it had acquired Synthorx, Inc. ( THOR ) for approximately $68 per share in cash, for a total value of $2.5 billion. This is a solid deal for Sanofi, because it will allow the company to obtain a drug known as THOR-707, which holds promise as a next generat...

NEW YORK, Dec. 21, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Audentes Therapeutics, Inc. (NASDAQ: BOLD) The investigation concerns whether Audentes and its board of directors violated the federal se...

Aimmune Therapeutics (NASDAQ: AIMT ) initiated with Neutral rating and $33 (4% upside) price target at H.C. Wainwright. More news on: Aimmune Therapeutics, Inc., Ampio Pharmaceuticals, Inc., Apellis Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Merger activity decreased with four new deals announced and two deals closing. Deal Statistics: New Deals: The acquisition of Diplomat Pharmacy (DPLO) by OptumRx for $300 million or $4.00 per share in cash. The acquisition of Synthorx (THOR) by Sanofi (SNY) for $2.35 billio...

NEW YORK, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Audentes Therapeutics, Inc. (NASDAQ: BOLD) The investigation concerns whether Audentes and its board of directors violated the federal secu...

As the year comes to a close, Sanofi (NASDAQ: SNY) has a holiday gift for investors in the form of a new strategy. The French drugmaker announced a $2.5 billion biotech takeover in the growing immuno-oncology field earlier this week, then a day later said it is dropping research in the dia...

NEW YORK, NY / ACCESSWIRE / December 13, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Synthorx, Inc ( THOR ) relating to its sa...

NEW YORK, NY / ACCESSWIRE / December 12, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: William Lyon Homes ( WLH ) related to its...